rs760330010
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_001148.6(ANK2):c.4791T>C(p.Asp1597Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000889 in 1,461,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: not found (cov: 32) 
 Exomes 𝑓:  0.0000089   (  0   hom.  ) 
Consequence
 ANK2
NM_001148.6 synonymous
NM_001148.6 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.254  
Publications
0 publications found 
Genes affected
 ANK2  (HGNC:493):  (ankyrin 2) This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Ankyrins play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. The protein encoded by this gene is required for targeting and stability of Na/Ca exchanger 1 in cardiomyocytes. Mutations in this gene cause long QT syndrome 4 and cardiac arrhythmia syndrome. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2011] 
ANK2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
- Brugada syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
- heart conduction diseaseInheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
- neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: G2P
- cardiac arrhythmia, ankyrin-B-relatedInheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- long QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85). 
BP6
Variant 4-113353409-T-C is Benign according to our data. Variant chr4-113353409-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 457039.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=-0.254 with no splicing effect.
BS2
High AC in GnomAdExome4 at 13 AD,Unknown gene. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
32
GnomAD2 exomes  AF:  0.0000200  AC: 5AN: 250340 AF XY:  0.00   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
5
AN: 
250340
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00000889  AC: 13AN: 1461802Hom.:  0  Cov.: 32 AF XY:  0.00000550  AC XY: 4AN XY: 727208 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
13
AN: 
1461802
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
4
AN XY: 
727208
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33474
American (AMR) 
 AF: 
AC: 
5
AN: 
44722
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26134
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39688
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53402
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
6
AN: 
1111962
Other (OTH) 
 AF: 
AC: 
1
AN: 
60394
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.463 
Heterozygous variant carriers
 0 
 1 
 2 
 4 
 5 
 6 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
32
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Long QT syndrome    Benign:1 
May 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.